Skip to main content

The Institut Bordet Clinical Haematology Department specialises in determining and treating diseases of the blood.

The Institut Bordet is committed to the treatment of these diseases and to offering patients high-quality, individual treatment.

In addition to the traditional approach to blood diseases, the Institut is also engaged in the development of innovative and complex techniques and therapies.

The Institut’s mission covers three main university fields: clinical, research and teaching.

The multidisciplinary nature of the Department, in both its diagnostic and therapeutic approaches, forms an integral part of all decisions concerning the patient.

Research projects

Participation of the Hematology Department in research projects with the following laboratories :

EXPERIMENTAL HAEMATOLOGY LABORATORY (HEMEXP)
CLINICAL CELLULAR THERAPY RESEARCH LABORATORY (LTCC)

 

Project 1

The prognostic value of cognitive function, biomarkers of ageing and clinical factors in elderly patients with malignant haemopathy admitted for chemotherapy (Dominique Bron, MD, PhD)
  • Project leader : Dominique Bron
  • Collaborations : H. Wildiers, M. Delforge (KUL)
  • Funding : Télévie, FNRS, Fonds Yvonne Boël

Project 2

Interculturality and Transplantation  

Project 3

Role of radio-immunotherapy in myeloma

Project 4

Protocoles de recherche clinique académiques et pharmaceutiques
  • Project leaders : Dominique Bron and colleagues
  • Funding : Fonds Ariane, Pharma

Our team

Head of Department
- Prof Nathalie Meuleman - Haematological Medicine (multiple myeloma and plasmocytary disorders, autografts)

Heads of Clinic
- Prof Philippe Lewalle - Haematological Medicine (myeloproliferative syndrome, chronic myeloid leukaemia and allogeneic transplants)
- Prof Sebastian Wittnebel - Haematological Medicine (leukaemia, myelodysplasia, new drugs and
allogeneic transplants)
- Dr Marie Maerevoet - Haematological Medicine (lymphomas and lymphoproliferative disorders, new drugs,
autografts)
- Dr Cécile Springael -
Haematological Medicine (T lymphomas and rare lymphomas)

Professor Emeritus
Prof Dominique Bron - Haematological Medicine (rare lymphoma and chronic lymphoid leukaemia)

Resident
- Dr Marie Vercruyssen - Haematological Medicine (multiple myeloma and plasmocytic disorders, autografts)
- Dr Chloé Spilleboudt
Haematological Medicine (leukemias, myelodysplasias and allogeneic transplantations)
- Dr
Adriano SalaroliHaematological Medicine (myeloproliferative syndromes, myelodisplasia, acute leukemias and transplantations, apheresis)
-  Dr Fulvio Massaro

Head Nursing (Tel : +32 (0)2 541 33 55)
Patrick Crombez

Nursing «coordinator of allografts » (Tel : +32 (0)2 541 33 30)
- Marie-France Jaivenois
- Rezarta Ayazi

Nurses (health care coordinators) (Tel : +32 (0)2 541 73 94)
- Sophie Delaunois
- Zilfi Balci
- Julie Kiss

Apheresis unit and Stem Cell Collection (Tel : +32 (0)2 541 32 11)
Philippe Lewalle - Responsible physician
- Adriano Salaroli - Resident
- Corine Mal - Nurse (Tel : +32 (0)2 541 32 74)
- Walter Bellemans - Nurse
- Munteanu Nicoleta - Nurse
- Olivier Mugema - Nurse
- Denise Duthoit - Nurse

Transplantation Coordination (Tel : +32 (0)2 541 32 12)
- Sandra Michiels - Coordinator
- Redouane Rouas - Suppleant
- Anne De Meuter - Data Manager EBMT 

Hematology Clinical Research Unit
- Sabrina Costantini Head (Tel : +32 (0)2 541 36 47)
- Dominique De Poorter - Nurse (Tel : +32 (0)2 541 35 98)
- Delphine Léva - Nurse (Tel : +32 (0)2 541 33 57)
- Lina Adu Poku - Nurse  (Tel : +32 (0)2 541 39 11)
- Aude Bovenkamp - Administrative (Tel : +32 (0)2 541 72 05)

Quality Cell
- Aurélie Timmermans (Tel +32 (0)2 541 72 25)

Secretariat 
- Sabine Ackermans (Administration) - Tel : +32 (0)2 541 37 28
- Jennifer Marinus (Consultation) - Tel : +32 (0)2 541 36 84
- Nancy Martin (Consultation) - Tel : +32 (0)2 541 38 78
Marie-France Ebanga (Consultation) - Tel : +32 (0)2 541 36 84

25/02/2021

 Scientific publications

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.

Authors : Merryman RW, Castagna L, Giordano L, Ho VT, Corradini P, Guidetti A, Casadei B, Bond DA, Jaglowski S, Spinner MA, Arai S, Lowsky R, Shah GL, Perales MA, De Colella JMS, Blaise D, Herrera AF, Shouse G, Spilleboudt C, Ansell SM, Nieto Y, Badar T, Hamadani M, Feldman TA, Dahncke L, Singh AK, McGuirk JP, Nishihori T, Chavez J, Serritella AV, Kline J, Mohty M, Dulery R, Stamatoulas A, Houot R, Manson G, Moles-Moreau MP, Orvain C, Bouabdallah K, Modi D, Ramchandren R, Lekakis L, Beitinjaneh A, Frigault MJ, Chen YB, Lynch RC, Smith SD, Rao U, Byrne M, Romancik JT, Cohen JB, Nathan S, Phillips T, Joyce RM, Rahimian M, Bashey A, Ballard HJ, Svoboda J, Torri V, Sollini M, De Philippis C, Magagnoli M, Santoro A, Armand P, Zinzani PL, Carlo-Stella C
Year : 2021
Journal : Leukemia
Volume : 35
Pages : 2672-2683

Mantle cell lymphoma simulating inflammatory bowel disease.

Authors : Lifrange F, de Wind R, Spilleboudt C, Karfis I, Van Gossum A, Demetter P
Year : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pages : 125-127

Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study.

Authors : Thibaud V, Denève L, Dubruille S, Kenis C, Delforge M, Cattenoz C, Somme D, Wildiers H, Pepersack T, Lamy T, Bron D
Year : 2021
Journal : J Geriatr Oncol
Volume : 12
Pages : 902-908

PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads.

Authors : Artesi M, Hahaut V, Cole B, Lambrechts L, Ashrafi F, Marçais A, Hermine O, Griebel P, Arsic N, van der Meer F, Burny A, Bron D, Bianchi E, Delvenne P, Bours V, Charlier C, Georges M, Vandekerckhove L, Van den Broeke A, Durkin K
Year : 2021
Journal : Genome Biol
Volume : 22
Pages : 97

Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.

Authors : Goudsmit A, Cubilier E, Meert AP, Aftimos P, Stathopoulos K, Spilleboudt C, Loizidou A
Year : 2021
Journal : Support Care Cancer